(Q34976030)

5 August 2017

Migraine and psychiatric comorbidity: from theory and hypotheses to clinical application (English)

1 reference

5 August 2017

1 reference

1 reference

1 reference

Fred D Sheftell

1

1 reference

PubMed ID

12390624

5 August 2017

Susan J Atlas

series ordinal

2

1 reference

5 August 2017

1 October 2002

1 reference

5 August 2017

1 reference

5 August 2017

42

1 reference

5 August 2017

9

1 reference

5 August 2017

934-944

1 reference

5 August 2017

Munchausen by Internet

1 reference

https://api.crossref.org/works/10.1046%2FJ.1526-4610.2002.02217.X

Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1526-4610.2002.02217.X

The prevalence and distribution of major depression in a national community sample: the National Comorbidity Survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1526-4610.2002.02217.X

Development of a Rating Scale for Primary Depressive Illness

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1526-4610.2002.02217.X

A SELF-RATING DEPRESSION SCALE

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1526-4610.2002.02217.X

Depression as a contributing factor in cerebrovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1526-4610.2002.02217.X

Migraine, quality of life, and depression: a population-based case-control study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1526-4610.2002.02217.X

21 January 2018

Dopamine and migraine

1 reference

https://api.crossref.org/works/10.1046%2FJ.1526-4610.2002.02217.X

Practice parameter: evidence-based guidelines for migraine headache (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1526-4610.2002.02217.X

Relapse of depression in primary care. Rate and clinical predictors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1526-4610.2002.02217.X

Strategies for managing depression refractory to selective serotonin reuptake inhibitor treatment: a survey of clinicians

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1526-4610.2002.02217.X

Venlafaxine extended release (XR) for the prophylaxis of migraine and tension-type headache: A retrospective study in a clinical setting.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1526-4610.2002.02217.X

Quality of life in panic disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1526-4610.2002.02217.X

Panic disorder. Pathophysiology and drug treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1526-4610.2002.02217.X

The headache-specific locus of control scale: adaptation to recurrent headaches

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1526-4610.2002.02217.X

10.1046/J.1526-4610.2002.02217.X

21 January 2018

Identifiers

DOI

1 reference

5 August 2017

1 reference

PubMed ID

12390624